CHICAGO - A new cervical cancer drug offers the first good hope of extending life for women with advanced stages of the disease, a study published Sunday has found. Existing chemotherapy regimes are largely ineffective against advanced stages of cervical cancer, which kills 250,000 women worldwide every year. That's why early screening is so critical - regular Pap smears have managed to reduce deaths in wealthy countries by 80 percent.

"Women with advanced cervical cancer don't have many options," said lead study author Krishnansu Sujata Tewari, a professor of obstetrics and gynecology at the University of California Irvine. "We finally have a drug that helps women live longer."